Portland State University spinout DesignMedix has shut down after its phase 1 trial for an antimalaria treatment caused side effects.
The immuno-oncology company – co-founded by Juno Therapeutics, a spinout of several institutions – is reportedly seeking $250m to $300m in a Hong Kong offering.
American Express will acquire the SoftBank, UPS, Santander and Recruit-backed business lender's assets excluding its loan portfolio, for a reported price $350m lower than the valuation for its last round.
WuXi AppTec and Juno Therapeutics' immuno-oncology joint venture is reportedly seeking $250m to $300m in a Hong Kong offering.
The solar tracking technology provider is aiming for $207m in an IPO on Shanghai's Star Market having raised money in a Risen Solar-backed round last year.
Dick Clark Productions, Keshet and UTA have exited the online meme and video producer in a Warner Media Group purchase reportedly sized at about $85m.
Existing investors including Foxconn, SK Telecom and iA Financial could buy up to $80m of shares in the medical imaging system developer's initial public offering.
Eberhard Karls University of Tübingen's messenger RNA drug developer CureVac priced the offering at the top of its range.
GlaxoSmithKline Eli Lilly and Genmab-backed messenger RNA drug developer CureVac priced the offering at the top of its range.
The JD.com subsidiary is set to pay $432m for a majority stake in the GLP-backed logistics services provider through a mixture of primary and secondary investment.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
